Exelixis’ Cabometyx R&D On Track Despite Pivotal Kidney Cancer Setback

 
• By Ayisha Sharma
Blue and purple graphic image of pair of kidneys
There Could Be 15,000 Deaths Due To Kidney Cancer This Year • Source: Shutterstock

More from Clinical Trials

More from R&D